A new obesity drug co-developed by China’s Innovent Biologics Inc. and Eli Lilly & Co. has demonstrated significant weight loss in a late stage trial, paying the way for its approval in the country to compete with the blockbuster from Novo Nordisk A/S.
Paul Singer Is Pitching Wall Street's Own Brand of MAGAWith Macron Distracted, Germany Shuts Down Push for Joint EU DebtAsset-Backed Bond Market Is Helping to Fuel the Global AI BoomSigna Founder Benko’s Home Raided by Police in Fraud ProbeFrench Bonds Hint Investor Nerves Are Calming Ahead of ElectionNigeria Central Bank Head Cardoso Says Worst of Naira Volatility Is OverArnault Said to Have Bought Stake in Cartier Owner RichemontStar Quant Fund’s 38,650% Asset Jump Threatened by India...
6 Billion Nickel Smelter Project in IndonesiaExiting Coal Isn’t the Way to Net Zero, Australian Pension SaysLG Chem Says Trump Return Won’t Fundamentally Change Climate ActVietnam’s SeABank Plans to Issue Nation’s First Blue BondIndian Premier Modi to Visit Russia, Kremlin Aide SaysPaladin's uranium deal signals M&A push for rich Canadian depositsThelo to Raise $250 Million With Eye on Africa’s Giant Rail CorridorsMacklem: BOC can beat inflation without unemployment spikeBank of Canada...
Canada Latest News, Canada Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Eli Lilly’s Obesity Drug Crunch Shows Signs of Easing in JapanEli Lilly & Co.’s hefty investment in expanding production capacity for its popular weight-loss and diabetes drugs is starting to pay off in Japan, allowing the company to lift shipment controls it imposed in the country last year.
Read more »
Goldman Sees Obesity-Drug Market Growing to $130 Billion by 2030Goldman Sachs Group Inc. sees growing potential for the global market for weight-loss drugs by the end of the decade.
Read more »
Structure's obesity drug reduces more weight than expected in studyExplore stories from Atlantic Canada.
Read more »
Britain Poised to Offer Eli Lilly’s Weight-Loss Drug to PatientsEli Lilly & Co.’s Mounjaro is being recommended for weight loss for some UK patients with obesity, in draft guidance that could see the National Health Service offer a rival drug to Novo Nordisk A/S’s hit treatment Wegovy.
Read more »
Big Food Tries to Offset Obesity Drug Blow With Vitamins, MealsThe so-called Ozempic Revolution has wiped billions off the market value of food and drink companies. But new weight-loss drugs are giving a boost to at least one line of products that have sometimes previously faced sluggish demand: yogurt.
Read more »
Obesity drug used in Mounjaro and Zepbound may help treat dangerous sleep apneaA popular obesity drug may help treat a dangerous disorder in which people struggle to breathe while they sleep, a new study finds.
Read more »